- NEWS
New obesity definition sidelines BMI to focus on health
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Prices may be subject to local taxes which are calculated during checkout
Nature 637, 773-774 (2025)
doi: https://doi.org/10.1038/d41586-025-00123-1
References
Rubino, F. et al. Lancet Diabetes Endocrinol. https://doi.org/10.1016/S2213-8587(24)00316-4 (2025).
GBD 2019 Risk Factors Collaborators Lancet 396, 1223–1249 (2020).
Busetto, L. et al. Nature Med. 30, 2395–2399 (2024).
Crompvoets, P. I., Nieboer, A. P., van Rossum, E. F. C. & Cramm, J. M. Health Expect. 27, e13954 (2024).
Why BMI is flawed — and how to redefine obesity
How ‘miracle’ weight-loss drugs will change the world
Fat cells have a ‘memory’ of obesity — hinting at why it’s hard to keep weight off
Why do obesity drugs seem to treat so many other ailments?
How rival weight-loss drugs fare at treating obesity, diabetes and more
Anti-obesity drug has life-changing benefits for arthritis
Should young kids take the new anti-obesity drugs? What the research says